News

Anyone who buys shower gel is being warned to look out for common ingredients which could be harmful to your health, as well as to the environment. According to cosmetics firm Typology ...
Italian drugmaker Menarini has agreed to buy Stemline Therapeutics, bolting on an already-approved drug for a rare form of haematological cancer and establishing a beachhead in the US. Privately ...
Dr Sam's Flawless Neutralising Gel is a clinically formulated, dermatologist-developed product designed to soothe spots, combat pigmentation and reduce redness. The Flawless Neutralising Gel is ...
Menarini has secured EU approval for Orserdu, the first in a new class of oral selective oestrogen receptor degrader (SERD) drugs and the first innovation in endocrine therapy for advanced breast ...
Dr Sam's Flawless Neutralising Gel is a clinically formulated and dermatologist-developed skincare marvel, celebrated for its ability to soothe spots, address pigmentation, and diminish redness.
The DEPArray™ Kits streamline and optimize the analysis of FFPE samples by providing DEPArray™ users a fast and easy workflow, for a precise genetic analysis on pure cancer and stromal cell ...
Ampli1™ LowPass Kit applications include the characterization and investigation of genomic heterogeneity and evolution in tumor cell populations such as individual circulating tumor cells (CTCs ...
Bagnasco has received speaker’s honoraria and advisory board membership from AstraZeneca, Chiesi, Firma, GSK, Novartis, Menarini, Sanofi, and Zambon. Berti has received funding from GSK for advisory ...
Choroidal neovascularisation (CNV) is a common vision-threatening complication of myopia and pathological myopia. Despite significant advances in understanding the epidemiology, pathogenesis and ...